NRx Pharmaceuticals (NRXP)
(Delayed Data from NSDQ)
$3.54 USD
+0.40 (12.74%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $3.75 +0.21 (5.93%) 7:58 PM ET
3-Hold of 5 3
F Value A Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
NRXP 3.54 +0.40(12.74%)
Will NRXP be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for NRXP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for NRXP
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
NRx Pharmaceuticals, Inc. (NRXP) Advances While Market Declines: Some Information for Investors
NRXP: What are Zacks experts saying now?
Zacks Private Portfolio Services
NRx Pharmaceuticals (NRXP) Upgraded to Strong Buy: Here's What You Should Know
New Strong Buy Stocks for April 4th
Pick These Top-Ranked Stocks to Deck Up Your Christmas Tree
Other News for NRXP
CGC, GENE and HOLO among mid-day movers
12 Health Care Stocks Moving In Thursday's Intraday Session
Crude Oil Edges Lower; Bio-Path Holdings Shares Spike Higher
Why Las Vegas Sands Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Why Is Bio-Path (BPTH) Stock Up 89% Today?